Axogen share price today

(AXGN)

Axogen share price is $15.64 & ₹1,329.02 as on 21 Dec 2024, 2.30 'hrs' IST

$15.64

▲

0.79

(5.32%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Axogen share price in Dollar and Rupees. Guide to invest in Axogen from India. Also see the sentimental analysis on Indian investors investing in Axogen. Get details on the Indian mutual funds that are investing in Axogen. Get Analyst recommendations and forecasts along with all the Axogen's financials.

Axogen share price movements

Today's Low: $14.54
Today's High: $15.87
$15.64
7.03%
Downside
Day's Volatility :8.38%
Upside
1.45%
52 Weeks Low: $5.55
52 Weeks High: $15.90
$15.64
64.51%
Downside
52 Weeks Volatility :65.09%
Upside
1.64%

Axogen Returns

Period	Axogen, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	11.95%	-11.1%	0.0%
6 Months	116.32%	-6.0%	0.0%
1 Year	123.43%	2.7%	0.0%
3 Years	57.98%	0.6%	-19.7%

Axogen Key Statistics

in dollars & INR

Previous Close	$14.85
Open	$14.66
Today's High	$15.87
Today's Low	$14.54
Market Capitalization	$653.5M
Today's Volume	$1.1M
52 Week High	$15.9
52 Week Low	$5.55
Revenue TTM	$180.9M
EBITDA	$-1.8M
Earnings Per Share (EPS)	$-0.33
Profit Margin	-7.91%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-14.51%

How to invest in Axogen from India?

It is very easy for Indian residents to invest directly in Axogen from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Axogen stock in both Indian Rupees (INR) and US Dollars (USD). Search for Axogen or AXGN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Axogen or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Axogen shares which would translate to 0.054 fractional shares of Axogen as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Axogen, in just a few clicks!

Returns in Axogen for Indian investors in Rupees

Investment Value

₹1,00,000

Axogen investment value today

Current value as on today

₹2,25,625

Returns

₹1,25,625

(+125.62%)

Returns from Axogen Stock

₹1,23,429 (+123.43%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Axogen

-28%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Axogen on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -28% less investors are searching Axogen in the last 30 days versus the previous period.

Global Institutional Holdings in Axogen

First Light Asset Management, LLC
9.29%
BlackRock Inc
7.38%
Soleus Capital Management, L.P.
6.83%
Morgan Stanley - Brokerage Accounts
6.59%
Vanguard Group Inc
5.51%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
5.17%

Analyst Recommendation on Axogen

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Axogen(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Axogen

What analysts predicted

Upside of 15.09%

Current:

$15.64

Target:

$18.00

Insights on Axogen

Price Movement
In the last 7 days, AXGN stock has moved up by 10.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 41.37M → 48.64M (in $), with an average increase of 7.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -6.63M → -1.85M (in $), with an average increase of 124.4% per quarter
AXGN vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 52.8%

Axogen Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$83.9M	↑ 38.91%
Net Income	$-22.4M	↑ 114.42%
Net Profit Margin	-26.68%	↓ 9.39%

	FY19	Y/Y Change
Revenue	$106.7M	↑ 27.13%
Net Income	$-29.1M	↑ 30.03%
Net Profit Margin	-27.29%	↓ 0.61%

	FY20	Y/Y Change
Revenue	$112.3M	↑ 5.24%
Net Income	$-24.8M	↓ 14.83%
Net Profit Margin	-22.09%	↑ 5.2%

	FY21	Y/Y Change
Revenue	$127.4M	↑ 13.41%
Net Income	$-28.1M	↑ 13.15%
Net Profit Margin	-22.03%	↑ 0.06%

	FY22	Y/Y Change
Revenue	$138.6M	↑ 8.81%
Net Income	$-27.3M	↓ 2.59%
Net Profit Margin	-19.72%	↑ 2.31%

	FY23	Y/Y Change
Revenue	$159.0M	↑ 14.74%
Net Income	$-21.7M	↓ 20.56%
Net Profit Margin	-13.66%	↑ 6.06%

	Q2 FY23	Q/Q Change
Revenue	$38.2M	↑ 4.07%
Net Income	$-6.7M	↓ 0.75%
Net Profit Margin	-17.46%	↑ 0.84%

	Q3 FY23	Q/Q Change
Revenue	$41.3M	↑ 8.17%
Net Income	$-4.1M	↓ 38.6%
Net Profit Margin	-9.91%	↑ 7.55%

	Q4 FY23	Q/Q Change
Revenue	$42.9M	↑ 4.0%
Net Income	$-3.9M	↓ 4.79%
Net Profit Margin	-9.07%	↑ 0.84%

	Q1 FY24	Q/Q Change
Revenue	$41.4M	↓ 3.6%
Net Income	$-6.6M	↑ 70.43%
Net Profit Margin	-16.04%	↓ 6.97%

	Q2 FY24	Q/Q Change
Revenue	$47.9M	↑ 15.79%
Net Income	$-1.9M	↓ 71.05%
Net Profit Margin	-4.01%	↑ 12.03%

	Q3 FY24	Q/Q Change
Revenue	$48.6M	↑ 1.53%
Net Income	$-1.9M	↓ 3.28%
Net Profit Margin	-3.82%	↑ 0.19%

	FY18	Y/Y Change
Profit	$71.0M	↑ 38.93%

	FY19	Y/Y Change
Profit	$89.4M	↑ 25.84%

	FY20	Y/Y Change
Profit	$90.7M	↑ 1.52%

	FY21	Y/Y Change
Profit	$104.4M	↑ 15.11%

	FY22	Y/Y Change
Profit	$114.4M	↑ 9.59%

	FY23	Y/Y Change
Profit	$127.9M	↑ 11.74%

	Q2 FY23	Q/Q Change
Profit	$30.9M	↑ 3.24%

	Q3 FY23	Q/Q Change
Profit	$33.2M	↑ 7.44%

	Q4 FY23	Q/Q Change
Profit	$33.8M	↑ 1.61%

	Q1 FY24	Q/Q Change
Profit	$32.6M	↓ 3.39%

	Q2 FY24	Q/Q Change
Profit	$35.3M	↑ 8.35%

	Q3 FY24	Q/Q Change
Profit	$36.4M	↑ 3.09%

	FY18	Y/Y Change
Operating Cash Flow	$-17.9M	↑ 93.36%
Investing Cash Flow	$-98.2M	↑ 7498.8%
Financing Cash Flow	$109.8M	↑ 545.29%

	FY19	Y/Y Change
Operating Cash Flow	$-19.9M	↑ 11.25%
Investing Cash Flow	$27.3M	↓ 127.77%
Financing Cash Flow	$4.0M	↓ 96.33%

	FY20	Y/Y Change
Operating Cash Flow	$-9.6M	↓ 51.56%
Investing Cash Flow	$-17.0M	↓ 162.2%
Financing Cash Flow	$40.5M	↑ 904.07%

	FY21	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 39.26%
Investing Cash Flow	$-23.6M	↑ 39.42%
Financing Cash Flow	$20.5M	↓ 49.47%

	FY22	Y/Y Change
Operating Cash Flow	$-16.1M	↑ 19.85%
Investing Cash Flow	$-3.2M	↓ 86.47%
Financing Cash Flow	$1.8M	↓ 91.23%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$292.0K	↓ 103.93%
Investing Cash Flow	$14.3M	↓ 1922.14%
Financing Cash Flow	$898.0K	↑ 41.86%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.6M	↑ 456.85%
Investing Cash Flow	$6.0M	↓ 58.15%
Financing Cash Flow	$5.0K	↓ 99.44%

Axogen Technicals Summary

Sell

Neutral

Buy

Axogen is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Axogen Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Axogen, Inc.	19.39%	116.32%	123.43%	57.98%	-13.83%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Axogen, Inc.	NA	NA	0.0	0.08	-0.15	-0.03	NA	2.26
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Axogen, Inc.	Buy	$653.5M	-13.83%	NA	-7.91%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Axogen

it's time to rethink nerve repair! axogen (nasdaq: axgn) is a medical products company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. people suffer traumatic injuries or undergo surgeries that impact the function of their peripheral nerves daily. damage may cause loss of function and feeling. axogen is bringing the science of nerve repair to life with its avance® nerve graft which axogen believes is the first and only commercially available allograft for bridging nerve discontinuities, axoguard® nerve connector, a coaptation aid allowing for close approximation of severed nerves, and axoguard® nerve protector that protects nerves during the healing process.

Organization	Axogen
Employees	426
CEO	Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.
Industry	Health Technology

Management People of Axogen

Name	Title
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.	Chief Financial Officer
Ms. Karen Zaderej	Advisor
Mr. Erick DeVinney	Chief Innovation Officer
Mr. Todd Puckett	Vice President of Operations
Mr. Harold D. Tamayo	Vice President of Finance & Investor Relations
Mr. Marc A. Began	Executive VP, General Counsel & Chief Compliance Officer
Ms. Doris Quackenbush	Vice President of Sales
Mr. Jens Schroeder Kemp	Chief Marketing Officer
Dr. Ivica Ducic M.D., Ph.D.	Chief Medical Officer

Important FAQs about investing in Axogen from India :

What is Axogen share price today?

Axogen share price today stands at $15.64, Open: $14.66 ; Previous Close: $14.85 ; High: $15.87 ; Low: $14.54 ; 52 Week High: $15.90 ; 52 Week Low: $5.55. The stock opens at $14.66, after a previous close of $14.85. The stock reached a daily high of $15.87 and a low of $14.54, with a 52-week high of $15.90 and a 52-week low of $5.55.

Can Indians buy Axogen shares?

Yes, Indians can invest in the Axogen (AXGN) from India.

With INDmoney, you can buy Axogen at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Axogen at zero transaction cost.

How can I buy Axogen shares from India?

It is very easy to buy Axogen from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Axogen be purchased?

Yes, you can buy fractional shares of Axogen with INDmoney app.

What are the documents required to start investing in Axogen stocks?

To start investing in Axogen, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.